In recent trading session, Mylan N.V. (NASDAQ:MYL) saw 2,074,837 shares changing hands with its beta currently measuring 1.47. Company’s recent per share price level of $15.8 trading at $0.07 or 0.41% at recent trade assigns it a market valuation of $8.19 Billion. That current trading price of MYL’s stock is at a discount of -46.27% from its 52-week high price of $23.11 and is indicating a premium of 19.3% from its 52-week low price of $12.75. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.97 Million shares which gives us an average trading volume of 4.85 Million if we extend that period to 3-months.
For Mylan N.V. (MYL), analysts’ consensus is at an average recommendation of Overweight while assigning it a mean rating of 2.3. Splitting up the data highlights that, out of 17 analysts covering the stock, none rated the stock as a Sell while 2 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 9 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $1.17 in the current quarter.
Mylan N.V. (NASDAQ:MYL) trade information
Upright in the green today for gaining 0.41%, in the last five days MYL remained trading in the green while hitting it’s week-highest on Monday, Oct 12 when the stock touched $16.00- price level, adding 1.25% to its value on the day. Mylan N.V.’s shares saw a change of -21.39% in year-to-date performance and have moved 1.02% in past 5-day. Mylan N.V. (NASDAQ:MYL) showed a performance of -1.25% in past 30-days. Number of shares sold short was 45.06 Million shares which calculate 9.29 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $22 to the stock, which implies a rise of 39.24% to its current value. Analysts have been projecting $17 as a low price target for the stock while placing it at a high target of $27. It follows that stock’s current price would jump +70.89% in reaching the projected high whereas dropping to the targeted low would mean a loss of 7.59% for stock’s current value.
Mylan N.V. (MYL) estimates and forecasts
12 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $2.99 Billion for the same. And 9 analysts are in estimates of company making revenue of $3.26 Billion in the next quarter that will end in December 01, 2020. Company posted $2.96 Billion and $3.19 Billion of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 0.8% while estimating it to be 2.1% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -58% during past 5 years. In 2020, company’s earnings growth rate is likely to be around -95% while estimates for its earnings growth in next 5 years are of 2.35%
Mylan N.V. (NASDAQ:MYL)’s Major holders
Insiders are in possession of 1.37% of company’s total shares while institution are holding 87.96% percent of that, with stock having share float percentage of 89.19%. Investors also watch the number of corporate investors in a company very closely, which is 741 institutions for Mylan N.V. that are currently holding shares of the company. Wellington Management Company, LLP is the top institutional holder at MYL for having 58.09 Million shares of worth $934.04 Million. And as of June 29, 2020, it was holding 11.24% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group, Inc. (The), which was holding about 57.34 Million shares on June 29, 2020. The number of shares represents firm’s hold over 11.09% of outstanding shares, having a total worth of $922.08 Million.
On the other hand, Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of July 30, 2020, the former fund manager was holding 50185811 shares of worth $808.49 Million or 9.71% of the total outstanding shares. The later fund manager was in possession of 14.75 Million shares on June 29, 2020, making its stake of worth around $237.16 Million in the company or a holder of 2.85% of company’s stock.